Allurion Technologies, Inc. Earnings Per Share (Basic)
Allurion Technologies, Inc. (ALUR) reported Earnings Per Share (Basic) of -$0.46 per share for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-15.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-05-15
- Allurion Technologies, Inc. earnings per share, basic for the quarter ending 2026-03-31 was -$0.46.
- Allurion Technologies, Inc. earnings per share, basic for the quarter ending 2025-09-30 was -$1.53, a 144.87% decline year-over-year.
- Allurion Technologies, Inc. earnings per share, basic for the quarter ending 2025-06-30 was -$1.28.
- Allurion Technologies, Inc. earnings per share, basic for the quarter ending 2025-03-31 was -$0.31, a 129.81% decline year-over-year.
- Allurion Technologies, Inc. earnings per share, basic for fiscal 2025 was -$3.81.
- Allurion Technologies, Inc. earnings per share, basic for fiscal 2024 was -$3.20.
- Allurion Technologies, Inc. earnings per share, basic for fiscal 2023 was -$59.38.
- Allurion Technologies, Inc. earnings per share, basic for fiscal 2022 was -$37.75.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 3 month as first filed | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 6 month as first filed | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 9 month as first filed | Earnings Per Share, Basic 12 month | Earnings Per Share, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | -$0.46 10-Q · filed 2026-05-15 | |||||||
| 2025-12-31 | -$3.81 10-K · filed 2026-03-30 | |||||||
| 2025-09-30 | -$1.53 10-Q · filed 2025-11-17 | -$3.43 10-Q · filed 2025-11-17 | ||||||
| 2025-06-30 | -$1.28 10-Q · filed 2025-08-19 | -$1.79 10-Q · filed 2025-08-19 | ||||||
| 2025-03-31 | -$0.31 10-Q · filed 2026-05-15 | $1.54 10-Q · filed 2025-05-15 | -$3.01 derived: net income ÷ weighted average shares · filed 2026-05-15 | -$0.72 derived: net income ÷ weighted average shares · filed 2026-05-15 | -$3.61 derived: net income ÷ weighted average shares · filed 2026-05-15 | |||
| 2024-12-31 | -$3.71 derived: net income ÷ weighted average shares · filed 2026-03-30 | -$0.34 derived: net income ÷ weighted average shares · filed 2026-03-30 | -$3.90 derived: net income ÷ weighted average shares · filed 2026-03-30 | -$3.20 10-K · filed 2026-03-30 | -$11.64 10-K · filed 2025-03-27 | |||
| 2024-09-30 | $3.41 10-Q · filed 2025-11-17 | -$0.14 10-Q · filed 2024-11-13 | $0.18 derived: net income ÷ weighted average shares · filed 2025-11-17 | $1.13 10-Q · filed 2025-11-17 | -$0.10 10-Q · filed 2024-11-13 | -$9.15 derived: net income ÷ weighted average shares · filed 2025-11-17 | ||
| 2024-06-30 | -$4.34 10-Q/A · filed 2025-08-28 | -$0.05 10-Q · filed 2024-08-14 | -$3.30 10-Q/A · filed 2025-08-28 | $0.07 10-Q · filed 2024-08-14 | -$14.50 derived: net income ÷ weighted average shares · filed 2025-08-28 | -$27.00 derived: net income ÷ weighted average shares · filed 2025-08-28 | ||
| 2024-03-31 | $1.04 10-Q/A · filed 2025-08-28 | $0.12 10-Q · filed 2024-05-14 | -$10.16 derived: net income ÷ weighted average shares · filed 2025-08-28 | -$22.80 derived: net income ÷ weighted average shares · filed 2025-08-28 | -$39.29 derived: net income ÷ weighted average shares · filed 2025-08-28 | |||
| 2023-12-31 | -$11.22 derived: net income ÷ weighted average shares · filed 2025-08-28 | -$24.59 derived: net income ÷ weighted average shares · filed 2025-08-28 | -$43.01 derived: net income ÷ weighted average shares · filed 2025-08-28 | -$59.38 10-K/A · filed 2025-08-28 | -$2.31 10-K · filed 2024-03-26 | |||
| 2023-09-30 | -$13.56 10-Q/A · filed 2025-08-28 | -$0.54 10-Q · filed 2023-11-14 | -$33.07 derived: net income ÷ weighted average shares · filed 2025-08-28 | -$50.01 10-Q/A · filed 2025-08-28 | -$2.00 10-Q · filed 2023-11-14 | $4.20 derived: net income ÷ weighted average shares · filed 2025-08-28 | ||
| 2023-06-30 | -$20.95 10-Q/A · filed 2025-08-28 | -$2.96 10-Q · filed 2023-10-20 | -$38.05 10-Q/A · filed 2025-08-28 | -$5.38 10-Q · filed 2023-10-20 | $2.20 derived: net income ÷ weighted average shares · filed 2025-08-28 | $5.81 derived: net income ÷ weighted average shares · filed 2025-08-28 | ||
| 2023-03-31 | -$17.09 10-Q/A · filed 2025-08-28 | -$0.68 10-Q · filed 2024-05-14 | $0.84 derived: net income ÷ weighted average shares · filed 2025-08-28 | $2.85 derived: net income ÷ weighted average shares · filed 2025-08-28 | $5.09 derived: net income ÷ weighted average shares · filed 2025-08-28 | |||
| 2022-12-31 | $0.17 derived: net income ÷ weighted average shares · filed 2025-08-28 | $1.11 derived: net income ÷ weighted average shares · filed 2025-08-28 | $2.40 derived: net income ÷ weighted average shares · filed 2025-08-28 | -$37.75 10-K/A · filed 2025-08-28 | -$1.51 10-K · filed 2024-03-26 | |||
| 2022-09-30 | -$0.53 10-Q · filed 2023-11-14 | -$1.19 derived: net income ÷ weighted average shares · filed 2023-11-14 | -$1.03 10-Q · filed 2023-11-14 | |||||
| 2022-06-30 | -$0.82 10-Q · filed 2023-10-20 | -$1.78 10-Q · filed 2023-10-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Picard Medical, Inc. (PMI) | United States | $0.011B | -0.01 |
| NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) | United States | $0.012B | |
| Sintx Technologies, Inc. (SINT) | United States | $0.012B | -1.10 |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| CERENOME, INC. (CNSY) | United States | $0.014B | |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| SeaStar Medical Holding Corp (ICU) | United States | $0.015B | -1.14 |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B |